Bank of New York Mellon »

Atea Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-09-30 $602k 208k 2.90
2025-06-30 $721k 200k 3.60
2025-03-31 $607k 203k 2.99
2024-12-31 $710k 212k 3.35
2024-09-30 $713k 213k 3.35
2024-06-30 $881k 266k 3.31
2024-03-31 $968k 240k 4.04
2023-12-31 $779k 255k 3.05
2023-09-30 $964k 321k 3.00
2023-06-30 $1.2M 321k 3.74
2023-03-31 $1.0M 310k 3.35
2022-12-31 $1.5M 321k 4.81
2022-09-30 $1.7M 307k 5.69
2022-06-30 $1.9M 270k 7.10
2022-03-31 $2.0M 277k 7.22
2021-12-31 $2.5M 278k 8.93
2021-09-30 $9.1M 259k 35.06
2021-06-30 $4.2M 196k 21.48
2021-03-31 $2.7M 44k 61.79
2020-12-31 $1.5M 37k 41.78